JAK1 and infection: To test whether LPV‐treated HIV‐1‐induced ISG expression depended on IFN production or direct activation of ISGs, infections were repeated in the presence of the JAK1/2 inhibitor ruxolitinib (Quintas‐Cardama et al, 2010).